跳至主要内容
临床试验/NCT05305248
NCT05305248已完成不适用

Comparison of Sedation With Intravenous Remimazolam and Dexmedetomidine During Spinal Anesthesia : Prospective Randomized Study

Gangnam Severance Hospital1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2022年4月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
1
主要终点
MOAA/S score

研究概览

简要总结

Remimazolam is a benzodiazepine-binding site antagonist of the GABA receptor, metabolized by esterases, and exhibits a stable context-sensitive half-life of 6-7 minutes. Remimazolam has a high clearance rate and a small volume of distribution in the pharmacokinetic model. The US FDA has approved sedation for surgery. Although there have been studies on the use of remimazolam as a sedative for procedures such as endoscopy, there have been no reports of the use of remimazolam in spinal anesthesia. The purpose of this study is to compare and analyze the hemodynamics and recovery profile of patients undergoing surgery under spinal anesthesia by maintaining sedation with dexmedetomidine or remimazolam.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe cardiovascular or respiratory disease
  • Contraindication to spinal anesthesia
  • Heart block
  • Previous hepatectomy or liver transplant
  • Patients with moderate or more hepatic impairment (AST/ALT is more than 2.5 times the upper limit of normal)
  • Estimated glomerular filtration rate < 30 mL/min/1.73m2
  • Acute narrow angle glaucoma
  • Myasthesia gravis
  • Known allergy to the drugs included in the study

排除标准

  • Patients 19 years of age or older who are expected to elective orthopedic surgery under spinal anaesthesia

研究组 & 干预措施

Remimazolam group

Experimental

Sedation with remimazolam during spinal anesthesia

干预措施: Remimazolam (Drug)

Dexmedetomidine group

Active Comparator

Sedation with dexmedetomidine during spinal anesthesia

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

MOAA/S score

时间窗: up to 30 minutes after PACU arrival

MOAA/S score will be evaluated by an 5-point scale from iniation of sedative drugs to 30 minutes after PCAU arrival at 10 minutes intervals.

次要结局

  • Sedation induction time Sedation induction time(up to 5 minutes after initation of sedative drugs)
  • Differences in basic vital signs between the two groups(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Do-Hyeong Kim

Professor

Gangnam Severance Hospital

研究点 (1)

Loading locations...

相似试验